Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Abrahamsson, Jonas  [Clear All Filters]
2024
Tierens A, Arad-Cohen N, Cheuk D, de Moerloose B, Navarro JMaria Fern, Hasle H, Jahnukainen K, Juul-Dam KLøvvik, Kaspers G, Kovalova Z, et al. Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease. J Clin Oncol. 2024:JCO2301841.
van Weelderen RElise, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, et al. Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia. Blood Adv. 2024.
2023
Karlsson L, Cheuk D, de Moerloose B, Hasle H, Jahnukainen K, Juul-Dam KLøvvik, Kaspers G, Kovalova Z, Lausen B, Nyström UNorén, et al. Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia. Br J Haematol. 2023.
van Weelderen RE, Klein K, Harrison CJ, Jiang Y, Abrahamsson J, Arad-Cohen N, Bart-Delabesse E, Buldini B, de Moerloose B, Dworzak MN, et al. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group. J Clin Oncol. 2023:JCO2202120.
2022
Nilsson T, Waraky A, Östlund A, Li S, Staffas A, Asp J, Fogelstrand L, Abrahamsson J, Palmqvist L. An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages. Int J Cancer. 2022.
2019
Mellgren K, Nierop AFM, Abrahamsson J. Use of multivariate immune reconstitution patterns to describe immune reconstitution after allogeneic stem cell transplantation in children. Biol Blood Marrow Transplant. 2019.
2016
Levinsen M, Harila-Saari A, Grell K, Jonsson OGisli, Taskinen M, Abrahamsson J, Vettenranta K, Åsberg A, Risteli J, Heldrup J, et al. Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016.
2015
Wlodarski MW, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, et al. Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents. Blood. 2015.